Tag: CHIKV
Valneva: new positive data in CHIKV – 05/13/2024 at 08:17
(CercleFinance.com) – Valneva announces new positive results in adolescents from the pivotal phase 3 study of its single-dose chikungunya virus (CHIKV) vaccine, results from the most recent analysis evaluating the…
Valneva: new positive data in CHIKV
(CercleFinance.com) – Valneva announces new positive results in adolescents from the pivotal phase 3 study of its single-dose chikungunya virus (CHIKV) vaccine, results from the most recent analysis evaluating the…
Valneva: positive immunogenicity data in CHIKV
(CercleFinance.com) – Valneva reports positive pivotal phase III results in adolescents regarding the immunogenicity of its single-injection live attenuated chikungunya virus (CHIKV) vaccine candidate, VLA1553. These pivotal data showed that…
Valneva: Positive immunogenicity data in CHIKV
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…